US CD68 Market Future Outlook and Industry Opportunities 2034
The US CD68 Market is supported by extensive biomedical research infrastructure and established pathology laboratories. Universities, cancer centers, and biotechnology companies use macrophage markers to investigate immune responses and disease mechanisms.
The CD68 Market was valued at US$ 804.62 million in 2025 and is expected to reach US$ 1,563.69 million by 2034 , registering a CAGR of...
